Skip to main content

Table 1 Active clinical trials of TKI therapies and immune checkpoint inhibitors in cancer patients

From: Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition

  1. Abbreviations: CML chronic myeloid leukemia, CRC colorectal cancer, GIST gastrointestinal stromal tumor, HCC hepatocellular carcinoma, HNSCC head and neck squamous cell carcinoma, NSCLC non-small cell lung cancer, RCC renal cell carcinoma, TNBC triple negative breast cancer
  2. * Biosimilar of Bevacizumab
  3. # bispecific antibody also binding to PD1
  4. $ Extracellular domain trap
Back to article page

Molecular Cancer

ISSN: 1476-4598